Ovarian cancer-specific markers set the stage for early diagnosis, personalized treatments

Six mRNA isoforms (bits of genetic material) produced by ovarian cancer cells but not normal cells have been identified by scientists, opening up the possibility that they could be used to diagnose early-stage ovarian cancer. What’s more, several of the mRNA isoforms code for unique proteins that could be targeted with new therapeutics. —> Read More